[Pharmacology of 4-hydroxy-5-methoxyisophthalic dialdoxime (dioxime of vanillic dialdehyde)].
D000284:Administration, Oral; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001833:Body Temperature Regulation / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D004597:Electroshock; D005260:Female; D005421:Flavoring Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D006339:Heart Rate / Q000187:drug effects; D007274:Injections, Intraperitoneal; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009043:Motor Activity / Q000187:drug effects; D010091:Oximes / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D010101:Oxygen Consumption / Q000187:drug effects; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D051381:Rats; D011919:Rats, Inbred Strains
D005421:Flavoring Agents; D010091:Oximes; D010433:Pentylenetetrazole
Pharmacologie du dialdoxime hydroxy 4  methoxy 5  isophthalique (doxime du dialdéhyde vanillique.